BioHarvest Sciences Inc. Common Stock
NASDAQ:BHST · NASDAQ Global Market
+$0.08 today
Vol 0.00M · Avg 0.03M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $19.2M |
| Receivables | $3.2M |
| Inventory | $5.0M |
| Other Current | $1.0M |
| Total Current Assets | $28.3M |
| PP&E (Net) | $16.8M |
| Long-term Investments | $436.0K |
| Total Non-current Assets | $17.2M |
| Total Assets | $45.6M |
Analysis
Selected assets total $45.6M for Latest. The largest visible component is Cash & Equivalents at $19.2M, about 42.1% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $23.0M +863.4% | $2.4M -55.4% | $5.4M +208.5% | $1.7M -57.8% | $4.1M | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $0 | $0 | $0 | $0 | $0 | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $2.2M +67.1% | $1.3M +38.6% | $968.0K +34.1% | $722.0K +16.5% | $620.0K | $533.8M | $399.4M | -$1.7B |
| Inventory | $4.6M +24.7% | $3.7M +48.2% | $2.5M +79.0% | $1.4M +48.5% | $928.0K | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $0 | $0 | $0 | $0 | $0 | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $30.5M +288.2% | $7.9M -13.2% | $9.1M +109.4% | $4.3M -23.7% | $5.7M | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $16.7M -0.3% | $16.8M +190.7% | $5.8M +17.6% | $4.9M +12.5% | $4.4M | $1.2B | $1.5B | $687.8M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $0 | $0 | $0 | $0 | $0 | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $0 | $0 | $0 | $0 | $0 | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $433.0K +16.7% | $371.0K +107.3% | $179.0K +9.8% | $163.0K -8.9% | $179.0K | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $17.2M +0.1% | $17.1M +188.2% | $6.0M +17.3% | $5.1M +11.6% | $4.5M | -$15.3B | $14.8B | $11.3B |
| Total Assets | $47.7M +90.7% | $25.0M +66.7% | $15.0M +59.7% | $9.4M -8.0% | $10.2M | $13.3B | $11.9B | $10.6B |
| Account Payables | $2.6M -25.5% | $3.5M +98.3% | $1.8M +66.6% | $1.1M +21.9% | $875.0K | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $149.0K -96.2% | $3.9M -81.0% | $20.5M +140.2% | $8.5M | $0 | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 | $0 | $0 | $0 | $0 | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $492.0K -62.2% | $1.3M +55.9% | $836.0K +112.2% | $394.0K | $0 | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $2.1M -43.0% | $3.7M +133.0% | $1.6M +124.9% | $698.0K -47.6% | $1.3M | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $7.7M -46.1% | $14.3M -46.1% | $26.5M +129.8% | $11.5M +294.1% | $2.9M | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $2.4M | $0 | $0 | $0 | $0 | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 -100.0% | $2.0M +10.6% | $1.8M | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $2.0M +629.0% | $272.0K -86.1% | $2.0M +1495.9% | $123.0K -63.8% | $340.0K | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $14.5M +54.4% | $9.4M +177.8% | $3.4M -10.9% | $3.8M -14.2% | $4.4M | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $22.2M -6.1% | $23.7M -20.7% | $29.9M +94.9% | $15.3M +108.4% | $7.4M | $14.7B | $3.7B | $9.6B |
| Common Stock | $133.0M +36.1% | $97.7M +42.4% | $68.7M +5.6% | $65.0M +3.9% | $62.6M | $651.4M | $517.0M | $382.6M |
| Retained Earnings | -$107.6M -11.5% | -$96.4M -15.5% | -$83.5M -17.7% | -$70.9M -18.8% | -$59.7M | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | $0 | $0 | $0 | $0 | $0 | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $0 | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $1.4B | $337.8M | $931.4M |
| Total Equity | $25.4M +1813.4% | $1.3M +109.0% | -$14.9M -150.5% | -$5.9M -307.7% | $2.9M | $9.1B | $7.7B | $3.3B |
| Total Debt | $14.1M +2.1% | $13.8M -38.1% | $22.3M +111.6% | $10.6M +297.1% | $2.7M | $724.2M | $410.6M | $399.4M |
| Net Debt | -$8.9M -178.1% | $11.4M -32.7% | $17.0M +92.5% | $8.8M +705.1% | -$1.5M | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
TRX Gold Corporation
AMEX:TRX
$296.96M
Friedman Industries, Incorporated
NASDAQ:FRD
$262.09M
Core Molding Technologies, Inc.
AMEX:CMT
$210.43M
FutureFuel Corp.
NYSE:FF
$186.86M
Ascent Industries Co.
NASDAQ:ACNT
$126.04M
U.S. GoldMining Inc.
NASDAQ:USGO
$110.31M
American Vanguard Corporation
NYSE:AVD
$74.66M
Mercer International Inc.
NASDAQ:MERC
$58.21M
Bioceres Crop Solutions Corp.
BIOX
$24.88M
Lavoro Limited
LVRO
$15.06M
SEC Filings
Recent regulatory filings
No filings found.
How much cash does BHST have?
BioHarvest Sciences Inc. Common Stock (BHST) reported $23.02M in cash and equivalents in fiscal 2025.
How much debt does BHST carry?
BioHarvest Sciences Inc. Common Stock (BHST) reported $14.10M of total debt, with net debt of -$8,921,000.00.
Explore More
Continue the stock analysis
Jump to another research area for this company.